Clinical Trials List
Protocol NumberFHBEBAT820230112
Completed
2023-12-01 - 2025-12-31
Phase I/II
Recruiting1
ICD-10C11.0
Malignant neoplasm of superior wall of nasopharynx
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9147.0
Malignant neoplasm of superior wall of nasopharynx
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/08/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
24 participants
